S'abonner

Use of Patient-specific MRI-based Prostate Mold for Validation of Multiparametric MRI in Localization of Prostate Cancer - 06/08/12

Doi : 10.1016/j.urology.2011.10.002 
Hari Trivedi a, Baris Turkbey b, Ardeshir R. Rastinehad c, Compton J. Benjamin c, Marcelino Bernardo b, d, Thomas Pohida e, Vijay Shah b, d, Maria J. Merino f, Bradford J. Wood a, W. Marston Linehan c, Aradhana M. Venkatesan a, Peter L. Choyke b, Peter A. Pinto a, c,
a Center for Interventional Oncology, Radiology and Imaging Sciences, Clinical Center, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 
b Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 
c Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 
f Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 
d Imaging Physics, SAIC Frederick, Inc., National Cancer Institute–Frederick, Frederick, Maryland 
e Division of Computational Bioscience, Center for Information Technology, National Institutes of Health, Bethesda, Maryland 

Reprint requests: Peter A. Pinto, M.D. Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, MSC 1210, Building 10, Room 2-5940, Bethesda, MD 20892-1088

Résumé

Objective

To demonstrate the use of a patient-specific magnetic resonance imaging (MRI)-based prostate mold to generate histologic sections that directly correlate to axial MRI slices in a patient with anteriorly located prostate cancer. Anteriorly located prostate cancer has traditionally been difficult to detect on digital rectal examination and transrectal ultrasound-guided biopsy. Multiparametric MRI has potential as a valuable tool for the diagnosis and focal treatment of prostate cancer. A significant difficulty to date has been accurate correlation between the magnetic resonance images and histopathologic specimens.

Methods

A patient-specific mold from a preoperative T2-weighted MRI scan was created to hold and shape the prostate specimen. Slots for slicing were positioned at 6-mm increments coplanar to the axial MRI slices. After surgical excision, the specimen was inked to maintain the orientation and fixed in formalin. The seminal vesicles were excised, and the prostate was oriented in the mold such that the color-coding matched the anatomic labels on the mold. The specimen was sliced with a single blade and the resultant 6-mm tissue blocks were used for histologic analysis.

Results

Preoperative multiparametric MRI revealed a lesion in the right anterior transition zone that was positive on T2-weighed MRI, apparent diffusion coefficient maps of diffusion-weighted MRI, magnetic resonance spectroscopy, and dynamic contrast-enhanced MRI. The histologic sections obtained using the mold demonstrated a similar Gleason score 6 (3 + 3) lesion in the right anterior transition zone, correlating with the MRI findings.

Conclusion

The use of patient-specific prostate molds to register the MRI findings with the histopathologic specimen in prostate cancer could offer several benefits compared with current specimen processing techniques. This technique might further validate MRI as an accurate tool for prostate cancer localization and staging.

Le texte complet de cet article est disponible en PDF.

Plan


 Funding Support: This study was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and Center for Cancer Research. This research was supported in part through the Clinical Research Training Program, a public-private partnership supported jointly by the National Institutes of Health and Pfizer, Inc. (by a grant to the Foundation for National Institutes of Health from Pfizer, Inc.).


© 2012  Publié par Elsevier Masson SAS.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 79 - N° 1

P. 233-239 - janvier 2012 Retour au numéro
Article précédent Article précédent
  • Reply
  • Mohammed Lezrek, Kamal Moufid, Mohammed Asseban, Khalil Bazine, El Hassan Kasmaoui, Mohammed Alami, Amoqrane Beddouch
| Article suivant Article suivant
  • Up-regulation of Plakophilin-2 and Down-regulation of Plakophilin-3 are Correlated With Invasiveness in Bladder Cancer
  • Hisaya Takahashi, Hiroyoshi Nakatsuji, Masayuki Takahashi, Shiirevnyamba Avirmed, Tomoya Fukawa, Masahiko Takemura, Tomoharu Fukumori, Hiroomi Kanayama

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2025 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.